Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen analysts that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, seven have given a buy recommendation and one has […]
Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price objective raised by Needham & Company LLC from $65.00 to $66.00 in a research note issued to investors on Monday morning, Marketbeat.com reports. They currently have a buy rating on the biotechnology company’s stock. Several other equities analysts have also commented on the company. Guggenheim boosted […]
Blueprint Medicines Co. (NASDAQ:BPMC) Position Increased by NBW Capital LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $66.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.